|
1
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi
X and Hoang BH: The WNT signaling pathway: Implications for therapy
in osteosarcoma. Expert Rev Anticancer Ther. 11:1223–1232. 2012.
View Article : Google Scholar
|
|
3
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayden JB and Hoang BH: Osteosarcoma:
Basic science and clinical implications. Orthop Clin North Am.
37:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dass CR, Ek ET, Contreras KG and Choong
PF: A novel orthotopic murine model provides insights into cellular
and molecular characteristics contributing to human osteosarcoma.
Clin Exp Metastasis. 23:367–380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Link MP, Goorin AM, Miser AW, Green AA,
Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick
JA, et al: The effect of adjuvant chemotherapy on relapse-free
survival in patients with osteosarcoma of the extremity. N Engl J
Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paul S and Dey A: Wnt signaling and cancer
development: Therapeutic implication. Neoplasma. 55:165–176.
2008.PubMed/NCBI
|
|
8
|
Cleton-Jansen AM, Anninga JK, Briaire-de
Bruijn IH, Romeo S, Oosting J, Egeler RM, Gelderblom H, Taminiau AH
and Hogendoorn PC: Profiling of high-grade central osteosarcoma and
its putative progenitor cells identifies tumourigenic pathways. Br
J Cancer. 101:1909–1918. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kirikoshi H, Sekihara H and Katoh M:
WNT10AWNT6, clustered in human chromosome 2q35 region with
head-to-tail manner, are strongly coexpressed in SW480 cells.
Biochem Biophys Res Commun. 283:798–805. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katoh MWNTFGF gene clusters (Review). Int
J Oncol. 21:1269–1273. 2002.PubMed/NCBI
|
|
11
|
Lavery DL, Davenport IR, Turnbull YD,
Wheeler GN and Hoppler S: Wnt6 expression in epidermis and
epithelial tissues during Xenopus organogenesis. Dev Dyn.
237:768–779. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geetha-Loganathan P, Nimmagadda S, Huang
R, Scaal M and Christ B: Role of Wnt-6 in limb myogenesis. Anat
Embryol (Berl). 211:183–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Ren L, Peng L, Xu P, Dong G and Ye
L: Effect of Wnt6 on human dental papilla cells in vitro. J Endod.
36:238–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lavery DL, Martin J, Turnbull YD and
Hoppler S: Wnt6 signaling regulates heart muscle development during
organogenesis. Dev Biol. 323:177–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakatsu MN, Ding Z, Ng MY, Truong TT, Yu F
and Deng SX: Wnt/β-catenin signaling regulates proliferation of
human cornea epithelial stem/progenitor cells. Invest Ophthalmol
Vis Sci. 52:4734–4741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hao J, Li TG, Qi X, Zhao DF and Zhao GQ:
WNT/β-catenin pathway up-regulates Stat3 and converges on LIF to
prevent differentiation of mouse embryonic stem cells. Dev Biol.
290:81–91. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galbraith RL, Poole EM, Duggan D, Muehling
J, Hsu L, Makar K, Xiao L, Potter JD and Ulrich CM: Polymorphisms
in WNT6 and WNT10A and colorectal adenoma risk. Nutr Cancer.
63:558–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad Orthop
Surg. 17:515–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krawetz R and Kelly GM: Wnt6 induces the
specification and epithelialization of F9 embryonal carcinoma cells
to primitive endoderm. Cell Signal. 20:506–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan G, Regel I, Lian F, Friedrich T,
Hitkova I, Hofheinz RD, Ströbel P, Langer R, Keller G, Röcken C, et
al: WNT6 is a novel target gene of caveolin-1 promoting
chemoresistance to epirubicin in human gastric cancer cells.
Oncogene. 32:375–387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qurrat-Ul-Ain Seemab U, Nawaz S and Rashid
S: Integrative analyses of conserved WNT clusters and their
co-operative behaviour in human breast cancer. Bioinformation.
7:339–346. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kohno H, Amatya VJ, Takeshima Y, Kushitani
K, Hattori N, Kohno N and Inai K: Aberrant promoter methylation of
WIF-1SFRP124 genes in mesothelioma. Oncol Rep. 24:423–431.
2010.PubMed/NCBI
|
|
23
|
Guo Y, Guo W, Chen Z, Kuang G, Yang Z and
Dong Z: Hypermethylation and aberrant expression of Wnt-antagonist
family genes in gastric cardia adenocarcinoma. Neoplasma.
58:110–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu D, Wong P, Li W, Vogel CF and Matsumura
F: Suppression of WIF-1 through promoter hypermethylation causes
accelerated proliferation of the aryl hydrocarbon receptor (AHR)
overexpressing MCF10AT1 breast cancer cells. Toxicology.
285:97–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
